Oulès, Bénédicte

Ryanodine receptor blockade reduces amyloid-β load and memory impairments in Tg2576 mouse model of Alzheimer disease. [electronic resource] - The Journal of neuroscience : the official journal of the Society for Neuroscience Aug 2012 - 11820-34 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1529-2401

10.1523/JNEUROSCI.0875-12.2012 doi


Alzheimer Disease--complications
Aminophenols--therapeutic use
Amyloid Precursor Protein Secretases--genetics
Amyloid beta-Peptides--metabolism
Amyloid beta-Protein Precursor--genetics
Analysis of Variance
Animals
Brain--cytology
Caffeine--pharmacology
Calcium--metabolism
Calcium Channel Blockers--therapeutic use
Cells, Cultured
Cytosol--drug effects
Dantrolene--pharmacology
Disease Models, Animal
Embryo, Mammalian
Endoplasmic Reticulum--drug effects
Enzyme Inhibitors--therapeutic use
Exploratory Behavior--drug effects
Gene Expression Regulation--drug effects
Humans
Inositol 1,4,5-Trisphosphate Receptors--genetics
Maleimides--therapeutic use
Maze Learning--drug effects
Membrane Potentials--drug effects
Membrane Proteins--metabolism
Memory Disorders--drug therapy
Mice
Mice, Transgenic
Muscle Relaxants, Central--pharmacology
Mutation--genetics
Nerve Tissue Proteins--metabolism
Neuroblastoma--pathology
Neurons--drug effects
Patch-Clamp Techniques
Peptide Fragments--metabolism
Phosphorylation--drug effects
Plaque, Amyloid--metabolism
Purines--therapeutic use
RNA, Messenger--metabolism
Reaction Time--drug effects
Recognition, Psychology--drug effects
Roscovitine
Ryanodine Receptor Calcium Release Channel--genetics
Transfection